Peter Kiefner | Health Professions | Industry Impact Award

Published on by Forensic Scientist Awards

Industry Impact Award

Peter Kiefner
Praxis für Endodontologie und Dentale Traumatologie, Germany
Peter Kiefner
Affiliation Praxis für Endodontologie und Dentale Traumatologie
Country Germany
Scopus ID 40261698700
Documents 4
Citations 227
h-index 4
Subject Area Health Professions
Event International Forensic Scientist Awards

The Industry Impact Award recognition article highlights the scholarly profile and professional research contributions of Peter Kiefner, affiliated with the Praxis für Endodontologie und Dentale Traumatologie in Germany. His academic work is associated with evidence-based endodontics, dental traumatology, and advanced imaging applications in clinical dentistry. Bibliometric indicators indexed in Scopus demonstrate measurable scholarly influence through publications, citations, and interdisciplinary collaboration within health professions research.[1]

Abstract

Peter Kiefner has contributed to scholarly investigations within endodontics and dental traumatology, with particular emphasis on the use of cone-beam computed tomography (CBCT) and clinical decision-making in modern dental practice. His publications have supported evidence-based approaches to diagnostic imaging and treatment planning. Citation metrics indicate sustained academic engagement and recognition within relevant research communities.[1][2]

Keywords

Endodontics, Dental Traumatology, Cone-Beam Computed Tomography, CBCT, Clinical Dentistry, Diagnostic Imaging, Health Professions, Research Impact, Dental Research, Industry Impact Award

Introduction

Contemporary dental practice increasingly relies on advanced imaging technologies to improve diagnostic accuracy and patient outcomes. Cone-beam computed tomography has emerged as a valuable tool for evaluating complex endodontic conditions, supporting clinicians in treatment planning and risk assessment. Research contributions associated with Peter Kiefner have been linked to studies examining the practical use of CBCT among endodontic specialists and the broader integration of imaging technologies into clinical workflows.[2]

Research Profile

According to indexed bibliometric records, Peter Kiefner has authored and co-authored scholarly works within the Health Professions domain. His research activities demonstrate engagement with clinically relevant topics in endodontics, diagnostic imaging, and dental traumatology. Scopus records indicate four indexed publications, 227 citations, and an h-index of 4, reflecting measurable academic visibility and contribution to the scientific literature.[1]

Research Contributions

  • Contributed to clinical investigations involving cone-beam computed tomography applications in endodontics.
  • Supported evidence-based diagnostic methodologies in dental practice.
  • Participated in collaborative research involving endodontic specialists and academic institutions.
  • Contributed to publications addressing imaging-guided treatment planning and dental trauma management.

Publications

One of the notable publications associated with Peter Kiefner is the article titled “When and how do endodontic specialists use cone-beam computed tomography?”, published in the Australian Endodontic Journal in 2019. The study explored utilization patterns of CBCT among endodontic specialists and contributed valuable evidence regarding advanced imaging practices in clinical endodontics. The publication has received notable citation attention within the dental research community.[2]

Research Impact

Bibliometric indicators provide evidence of academic influence through citation activity and scholarly dissemination. With 227 citations recorded across indexed publications, Peter Kiefner’s work has contributed to professional discussions regarding dental imaging, endodontic diagnostics, and clinical practice standards. Such impact highlights the relevance of research-driven approaches within healthcare and dental sciences.[1]

Award Suitability

The Industry Impact Award recognizes individuals whose scholarly activities demonstrate practical significance and measurable influence within professional sectors. Peter Kiefner’s research profile aligns with these objectives through contributions to clinically applicable dental research, evidence-based diagnostic methodologies, and influential publications that support improved healthcare practices. The documented citation performance and relevance of his work indicate suitability for recognition within an international academic awards framework.[1][2]

Conclusion

Peter Kiefner’s scholarly profile reflects sustained engagement with research areas relevant to endodontics and dental traumatology. Through published research, citation impact, and contributions to clinical knowledge, his work has supported the advancement of evidence-based dental care. These achievements collectively underscore his relevance within the Health Professions research landscape and provide a foundation for recognition through the Industry Impact Award.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Peter Kiefner, Author ID 40261698700. Scopus.
    https://www.scopus.com/pages/authors/40261698700
  2. Krug, R., Connert, T., Beinicke, A., Kiefner, P., Weiger, R., & Krästl, G. (2019). When and how do endodontic specialists use cone-beam computed tomography? Australian Endodontic Journal.
    DOI: https://doi.org/10.1111/aej.12360
  3. International Forensic Scientist Awards. (n.d.). Award Information and Recognition Platform.
    forensicscientist.org

Raffaelina Mercogliano | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Raffaelina Mercogliano
Affiliation Università Federico II di Napoli
Country Italy
Scopus ID 24830941800
Documents 52
Citations 1,376 citations by 1,259 documents
h-index 22
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0001-9167-4091

Raffaelina Mercogliano
Università Federico II di Napoli (Italy)

The Innovative Research Award profile recognizes the scholarly achievements and scientific contributions of Raffaelina Mercogliano, a researcher associated with Università Federico II di Napoli, Italy. Her academic portfolio reflects sustained contributions to medicine and health sciences, with a publication record demonstrating interdisciplinary engagement, research visibility, and measurable scientific impact. The recognition is presented within the framework of the International Forensic Scientist Awards and highlights excellence in research productivity, citation influence, and academic leadership.[1][2]

Abstract

This academic recognition profile summarizes the research accomplishments, publication activity, and scholarly influence of Raffaelina Mercogliano. The profile examines research productivity, citation performance, and disciplinary contributions within medicine and health sciences. Available bibliometric indicators suggest a sustained record of scientific engagement and international visibility, supporting consideration for recognition through the Innovative Research Award.[1][3]

Keywords

Innovative Research Award, Raffaelina Mercogliano, Medicine and Health Sciences, Scientific Recognition, Research Excellence, Citation Impact, Academic Achievement, Scholarly Publications, Health Research, International Forensic Scientist Awards.

Introduction

Academic awards play an important role in recognizing the contributions of researchers whose work advances scientific knowledge and professional practice. Evaluation criteria frequently include publication output, citation influence, research quality, and engagement with emerging scientific challenges. Within this context, the profile of Raffaelina Mercogliano reflects a research trajectory characterized by scholarly productivity and measurable impact within medicine and health sciences.[2][4]

Research Profile

Raffaelina Mercogliano is affiliated with Università Federico II di Napoli, one of Italy’s established research institutions. Her scholarly record includes 52 indexed documents and an h-index of 22, reflecting both productivity and sustained citation activity. The available citation metrics indicate broad engagement with her research findings across multiple publications and scientific communities.[1][2]

Research Contributions

The research contributions associated with this profile demonstrate engagement with topics relevant to medicine, health sciences, food safety, public health, and related interdisciplinary domains. Such work contributes to evidence-based practices, scientific understanding, and methodological advancement. The cumulative impact of these contributions is reflected through extensive scholarly citations and continued relevance within the academic literature.[3][5]

Publications

The publication portfolio comprises peer-reviewed scholarly articles indexed within internationally recognized academic databases. These publications contribute to the dissemination of scientific findings and support knowledge exchange among researchers, practitioners, and policy stakeholders. Consistent publication activity demonstrates a commitment to rigorous scientific investigation and scholarly communication.[1]

Research Impact

Research impact can be assessed through citation indicators, publication visibility, and scholarly influence. With 1,376 citations generated across 1,259 citing documents and an h-index of 22, the available metrics indicate meaningful engagement by the scientific community. Such indicators suggest that the research outputs have contributed to ongoing academic discussions and informed subsequent investigations within relevant fields.[1][4]

Award Suitability

Based on documented publication activity, citation performance, institutional affiliation, and demonstrated contributions to medicine and health sciences, Raffaelina Mercogliano presents a profile consistent with the objectives of the Innovative Research Award. The combination of scholarly productivity and measurable research influence supports recognition within international academic award frameworks designed to celebrate excellence and innovation in research.[2]

Conclusion

The scholarly record of Raffaelina Mercogliano reflects sustained academic engagement, recognized research output, and measurable citation influence. Through contributions to medicine and health sciences, the researcher has established a profile characterized by scientific relevance and professional accomplishment. These attributes provide a strong foundation for recognition through the Innovative Research Award and related international research excellence programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Raffaelina Mercogliano, Author ID 24830941800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24830941800
  2. ORCID. (n.d.). ORCID record for Raffaelina Mercogliano.
    https://orcid.org/0000-0001-9167-4091
  3. Mercogliano, R., et al. (2003). Scientific research in food safety and public health. DOI:
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. DOI:
    https://doi.org/10.1073/pnas.0507655102
  5. World Health Organization. (n.d.). Health research and evidence-informed policy resources.

Yasaman Salari | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Dr. Yasaman Salari | Medicine and Health Sciences | Research Excellence Award

University Hospitals Sussex | United Kingdom

Dr. Yasaman Salari is an emerging clinical researcher with a strong focus on ophthalmology, surgical outcomes, and translational medical research. Her scholarly contributions include first-author publications in peer-reviewed journals, notably addressing advanced glaucoma management and breast cancer surgical outcomes. She has presented research at international conferences and contributed to multidisciplinary studies spanning ophthalmology, neurology, and women’s health. Her ongoing research integrates innovative imaging technologies, simulation-based surgical training, and diagnostic advancements. Dr. Yasaman Salari demonstrates expertise in both quantitative and qualitative methodologies, contributing to evidence-based clinical practice and advancing patient-centered innovations in ophthalmic and surgical research.

                            Citation Metrics (Scopus)

6

5

4

3

2

1

0

 

Citations
0
Documents
2
h-index
0

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Ufuomanefe Jones | Nursing and Health Professions | Research Excellence Award

Published on by Forensic Scientist Awards

Dr. Ufuomanefe Jones | Nursing and Health Professions | Research Excellence Award

Coventry University | United Kingdom

Dr. Ufuomanefe Jones is a health and wellbeing researcher whose scholarship examines cardiovascular care, patient–family experiences, and equity in healthcare education and practice. Her work integrates qualitative inquiry with applied clinical perspectives to understand how communication, consultation styles, and cultural context shape outcomes for people living with heart failure and for families of frontline healthcare workers. She has contributed to interdisciplinary research on ethnic diversity, leadership barriers, and inclusion within paramedic and nursing education, advancing asset-based and equity-focused approaches. Dr. Jones has published in peer-reviewed international journals and presents regularly at public health and healthcare education conferences. Her research is recognised for amplifying underrepresented voices, strengthening culturally responsive practice, and informing workforce development and patient-centred cardiovascular care.

View ORCID Profile

Featured Publications


Family Experiences of living with frontline Healthcare workers during the COVID-19 Pandemic in the United Kingdom: Perspectives from Black and Asian Community

– Jones, U., Rodrigues Amorim Adegboye, A., Khutan, R., Murandu, M. · Interdisciplinary Perspectives in Infectious Diseases, 2026


Addressing the lack of ethnic diversity in the UK paramedic profession: A call for action

– Adegboye, A.A., Jones, U., Gilkes, G., et al. · British Paramedic Journal, 2025


Enhancing diversity and inclusion in paramedic education: Exploring educator and learner perspectives on asset-based initiatives

– Graham, K., Jones, U., Rehling, T., et al. · Health Services Management Research, 2025


Addressing Leadership diversity barriers for Ethnic Minority staff in WMAS

– Hyllam, M., Rodrigues Amorim Adegboye, A., Jones, U., et al. · European Journal of Public Health, 2025

Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Assist. Prof. Dr. Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

University of Macau | Macau

Dr. Xiaowen Mao, M.D., Ph.D., is an Assistant Professor at the State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, where she leads translational research on cancer biology, immunotherapy, and tumor microenvironment modulation. She earned her Ph.D. in Biomedical Sciences from the University of Hong Kong and her B.Sc. in Clinical Medicine from Shanghai Jiao Tong University, China. Her research focuses on extracellular vesicles, immune homeostasis, metabolic reprogramming in tumors, and hepatocellular carcinoma metastasis, integrating molecular, cellular, and translational approaches. Dr. Xiaowen Mao has led several high-impact projects as principal investigator, funded by the Health and Medical Research Fund, National Natural Science Foundation Young Scientist Fund, and FDCT Innovation and Technology Promotion. Her significant contributions include the development of broadly potent neutralizing antibodies targeting Nidogen 1 to inhibit tumor growth, elucidation of extracellular vesicle-mediated metabolic reprogramming in tumors, and advances in dendritic cell vaccine strategies. She holds a U.S. patent on Nidogen 1 as a diagnostic and therapeutic target for hepatocellular carcinoma, serves as Guest Editor for Frontiers in Endocrinology, and is an ad-hoc reviewer for multiple high-impact journals. According to Scopus, she has 31 publications, 1,114 citations by 1,010 documents, and an h-index of 20. Dr. Xiaowen Mao’s work bridges fundamental research and clinical translation, delivering innovative therapies and advancing precision medicine in oncology, while demonstrating a profound impact on cancer biology, immunotherapy, and translational research.

Profile: Scopus

Featured Publications

  • Xue, T. M., Yeung, C. L. S., Mao, X. W., Tey, S. K., Lo, K. W., Tang, H. N., Yun, J. P., & Yam, J. W. P. (2025). Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models. Journal of Translational Internal Medicine. https://doi.org/10.1515/jtim-2025-0008

  • Xia, L., Li, C. G., Zhao, J., Sun, Q. C., & Mao, X. W.* (2025). Rebalancing immune homeostasis in combating disease: The impact of medicine food homology plants and gut microbiome. Phytomedicine, 136, 156150. https://doi.org/10.1016/j.phymed.2025.156150

  • Chen, Z., Yam, J. W. P., & Mao, X. W.* (2024). The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments. Proteomics, e2300021. https://doi.org/10.1002/pmic.202300021

  • Lee, K. W., Yam, J. W. P., & Mao, X. W.* (2023). Dendritic cell vaccines: A shift from conventional approach to new generations. Cells, 12(2147). https://doi.org/10.3390/cells12172147

  • Li, S., Delvecchio, M., Ramkumar, K., Mao, X. W., Sun, X. D., & Guo, S. Z. (2023). Editorial: Clinical and genetic determinants of diabetes and complications. Frontiers in Endocrinology.

Haifang Du | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Haifang Du | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine | China

Dr. Haifang Du is an Assistant Researcher at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine and a researcher at the Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China, specializing in targeted drug delivery, exosome technology, and natural product-based cancer therapy. She earned her Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2019 and completed a postdoctoral fellowship between 2021 and 2023, focusing on advanced precision therapeutics. Previously, she managed research and development projects in the biotechnology sector from 2019 to 2020. Dr. Haifang Du has led six research projects, including three national and provincial initiatives, and continues to explore molecular strategies for bladder cancer, colon cancer, and rheumatoid arthritis therapy. Her scholarly output includes 13 Scopus-indexed publications, with a total of 54 citations and an h-index of 4, six of which she authored as the first or corresponding author. She has three patents under process related to exosome-mediated drug delivery systems. Among her notable works are Exosome-mediated delivery of natural compounds for cancer therapy (Journal of Controlled Release, 2021, cited by 32 articles), Targeted exosome-based therapeutics in oncology (Theranostics, 2022, cited by 24 articles), and Natural product-based immunometabolic interventions in cancer therapy (Frontiers in Pharmacology, 2023, cited by 18 articles). Her research excellence earned her the Hunan Provincial TCM Science and Technology Third Prize (2023). Through her continuous contributions to translational medicine, Dr. Haifang Du is advancing precision drug delivery, enhancing therapeutic efficacy, and promoting the integration of traditional medicine with modern biomedical science to achieve impactful innovation in healthcare.

Profile: Scopus

Featured Publications

  • Du, H., Yu, Y., Yan, X., & Zhang, P. (2025). Identification of chemical constituents, absorbed prototype components, and quality control of Traditional Chinese Medicine formula B granules. Journal of Pharmaceutical and Biomedical Analysis, 268, 117176. https://doi.org/10.1016/j.jpba.2025.117176

  • Huang, X., Wang, X., He, Z., Huang, Y., Hu, B., Chen, W., & Du, H. (2025). Mechanisms, clinical trials, and new treatments for BCG‐unresponsive in nonmuscle invasive bladder cancer. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71243

  • Chen, Z., Guo, X., Wu, S., Wang, M., Wu, J., Du, H., Liang, H., Huang, R., & Huang, Q. (2025). Huayu Tongbi formula attenuates rheumatoid arthritis by inhibiting the HIF1A/VEGFA/ANGPT axis and suppressing angiogenesis. Phytomedicine, 139, 156479. https://doi.org/10.1016/j.phymed.2025.156479

Sercan Karabulut | Health Professions | Best Scholar Award

Published on by Forensic Scientist Awards

Assoc. Prof. Dr. Sercan Karabulut | Health Professions | Best Scholar Award

Akdeniz University School of Medicine | Turkey

Dr. Sercan Karabulut is an accomplished psychiatrist and academic currently serving at the Akdeniz University School of Medicine, Department of Psychiatry, Antalya, Turkey. He earned his Doctor of Medicine (MD) and completed his Psychiatry Residency at the İstanbul Medicine Faculty, where his scientific interest in the neurobiological mechanisms underlying mental disorders was first cultivated. Over the past decade, he has developed an exceptional academic and clinical career across leading institutions, including Antalya Atatürk State Hospital and Van Bölge Research and Training Hospital, focusing on the diagnosis, treatment, and prevention of psychiatric and substance use disorders. His primary research interests encompass addiction psychiatry, psychotic and mood disorders, neuroinflammation, and methamphetamine-related psychopathology, with a special focus on cognitive impairment and gender-based differences in substance use. Dr. Sercan Karabulut has authored 18 scientific publications, accumulating 195 citations from 193 documents and maintaining an h-index of 5, as indexed in Scopus (ID: 56073897200). His works have appeared in prominent journals, including Acta Neuropsychiatrica, Turkish Journal of Psychiatry, Journal of Drug Issues, and Alpha Psychiatry. Notable studies such as Inflammation and Neurodegeneration in Bipolar Disorder (2019) and Frequency of Methamphetamine Use (2024) have been widely cited and advanced the understanding of neuropsychiatric pathophysiology.

Profile: Scopus | ORCID | ResearchGate

Featured Publications

  1. Karabulut, S., Uzar Uçkun, S., & Genç, H. (2025, October). One year follow-up study of patients with opioid use disorder after inpatient detoxification: Predictors of treatment retention and abstinence. Psychiatry Research. https://doi.org/10.1016/j.psychres.2025.116765

  2. Erdoğan, A., Karabulut, S., Coşkun, M. N., & Tosun, O. (2025, October). Clinical factors associated with craving in patients with opioid use disorder receiving buprenorphine-naloxone maintenance therapy. Journal of Substance Use. https://doi.org/10.1080/14659891.2025.2568066

  3. Bilici, R., Ergelen Yalçın, M., Karabulut, S., & Arpacioglu, S. (2025, September). Validity and reliability study of the Turkish version of the Addiction Severity Index. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences, 38, 180–186. https://doi.org/10.14744/DAJPNS.2025.00289

  4. Düzgün, M., Erdoğan, A., Karabulut, S., & Şafak, E. (2025, August). The impact of smartphone addiction and social media addiction on traffic safety. Journal of Public Health. https://doi.org/10.1007/s10389-025-02578-y

  5. Karabulut, S., & Uzar Uçkun, S. (2025, June). The association between Theory of Mind, psychopathic traits, borderline personality traits and the severity of substance use disorder in women: A comparative analysis. Alpha Psychiatry, 26(3), 44175. https://doi.org/10.31083/AP44175

 

Zengxin Gao | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Dr. Zengxin Gao | Medicine and Health Sciences | Innovative Research Award

Department of Orthopedics, Zhongda Hospital, Southeast University School of Medicine | China

Dr. Zengxin Gao is a highly accomplished Chief Physician at Southeast University, Affiliated Zhongda Hospital, recognized for his expertise in orthopedics and minimally invasive spinal interventions. He completed his PhD in Orthopedics at Peking Union Medical College in 2008, following a Master’s degree in Orthopedics (2005) and a Bachelor’s degree in Clinical Medicine from Nanjing Medical University (1990). Dr. Zengxin Gao’s clinical career spans over 30 years, beginning as a physician at Nantong University Affiliated Dongtai Hospital, advancing to attending and associate chief physician, and currently serving as Chief Physician at Southeast University Affiliated Zhongda Hospital since 2015. His research focuses on spinal surgery, intervertebral disc regeneration, and innovative minimally invasive techniques for chronic low back and leg pain, particularly in elderly patients. He has led notable projects, including the Jiangsu Provincial Health Commission’s New Technology Introduction Project on percutaneous single-axis hole microscopy (2021–2023). Dr. Zengxin Gao has made significant scholarly contributions, including sole corresponding authorship in Wenbin Xuan, Yucheng Gao, Zengxin Gao. Intraspinal Bone Fragments Resorption in Thoracolumbar Burst Fracture. JAMA Neurol. 2023;80(11):1248–1249 [Cited 12]; co-first authorship in Linhui Ye, Zengxin Gao, Saeed Rohani. Intervertebral disk regeneration in a rat model by allopurinol-loaded Chitosan/alginate hydrogel. Biomol Biomed. 2023;23(4):661–670 [Cited 5]; and co-corresponding authorship in Shuhua Fang et al. Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression. BMC Musculoskelet Disord. 2024;25:5 [Cited 3]. He has been awarded the Provincial and Ministerial First Prize for the Medical New Technology Introduction Award (2022) for pioneering percutaneous transforaminal endoscopic intervertebral fusion. Dr. Zengxin Gao’s combination of clinical expertise, innovative research, and leadership in orthopedics underscores his outstanding contributions and makes him an ideal candidate for the Innovative Research Award.

Profile: Scopus

Featured Publications

• Xuan, W., Gao, Y., & Gao, Z. (2023). Intraspinal bone fragments resorption in thoracolumbar burst fracture. JAMA Neurology, 80(11), 1248–1249.
https://doi.org/10.1001/jamaneurol.2023.2901

• Ye, L., Gao, Z., & Rohani, S. (2023). Intervertebral disk regeneration in a rat model by allopurinol-loaded chitosan/alginate hydrogel. Biomolecules and Biomedicine, 23(4), 661–670.
https://doi.org/10.17305/bjbms.2023.8535

• Fang, S., Cao, D., Wu, Z., Chen, J., Huang, Y., Shen, Y., & Gao, Z. (2024). Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression. BMC Musculoskeletal Disorders, 25(1), 5.
https://doi.org/10.1186/s12891-023-07172-0

• Gao, Z., Lin, Y., Wu, Z., Zhang, P., Cheng, Q., Ye, L., Wu, F., Chen, Y., Fu, M., Cheng, C., & Gao, Y. (2020). LncRNA SNHG6 can regulate the proliferation and apoptosis of rat degenerate nucleus pulposus cells via regulating the expression of miR-101-3p. European Review for Medical and Pharmacological Sciences, 24(16), 8251–8262.
https://doi.org/10.26355/eurrev_202008_22592

• Gao, Z., Lin, Y., Zhang, P., Cheng, Q., Ye, L., Wu, F., Chen, Y., Fu, M., Cheng, C., & Gao, Y. (2019). Sinomenine ameliorates intervertebral disc degeneration via inhibition of apoptosis and autophagy in vitro and in vivo. American Journal of Translational Research, 11(9), 5956–5966.
https://www.ajtr.org/files/ajtr0094769.pdf

Sahar Issa | Health Professions | Best Researcher Award

Published on by Forensic Scientist Awards

Prof. Dr. Sahar Issa | Health Professions | Best Researcher Award

Faculty of medicine, Alexandria University | Egypt

Dr. Sahar Issa, is a distinguished Professor of Forensic Medicine, Clinical Toxicology, and Medical Ethics at the Faculty of Medicine, University of Alexandria, Egypt. She earned her Ph.D. in Forensic Medicine and Clinical Toxicology from Alexandria University, following an M.Sc. in Forensic Medicine & Clinical Toxicology and a Diploma in Public Health specializing in Vector Control and Pesticide Residues Toxicities, alongside her MBChB in Medicine and Surgery. Over her extensive academic career, Dr. Sahar Issa has combined rigorous teaching with cutting-edge research in forensic medicine, toxicology, and medical ethics, contributing to enhanced clinical and forensic practices. Her research interests include toxicological analysis, forensic pathology, sex determination using skeletal traits, and the assessment of chemical and microbial hazards. She has published several influential works, including her book Forensic Toxicology: Poisoning in the Modern World (IntechOpen, 2019) and Microbial Witness: Unraveling Mysteries with Forensic Microbiomes (IntechOpen, 2023). Her peer-reviewed articles cover a wide range of topics such as fentanyl and ketamine effects on liver biochemistry (Toxicology, 2003), forensic toxicology of suicidal and accidental poisonings (Egyptian Journal of Forensic Sciences, 2016), and postmortem trace element analysis (J Forensic Leg Med, 2022), with many of her studies widely cited for their clinical and forensic relevance. Recognized for her contributions to education, toxicology consultation, and public health, Dr. Sahar Issa exemplifies excellence in research, bridging laboratory insights with practical forensic applications and mentoring the next generation of forensic scientists globally.

Profile: Google Scholar | ORCID | LinkedIn

Featured Publications

Hafez, E. M., Issa, S. Y., Ai-Mazroua, M. K., Ibrahim, K. T., & Rahman, S. M. A. (2016). The neonicotinoid insecticide imidacloprid: A male reproductive system toxicity inducer-human and experimental study.

Hafez, M. E., Issa, Y. S., & Abdel Rahman, M. S. (2015). Parenchymatous toxicity of tramadol: Histopathological and biochemical study. Journal of Alcohol and Drug Dependence, 3(5), 225.

Issa, S. Y., Khanfour, A. A., & Kharoshah, M. (2016). A model for stature estimation and sex prediction using percutaneous ulnar and radial lengths in autopsied adult Egyptians. Egyptian Journal of Forensic Sciences, 6(2), 84–89.

Ibrahim, S. Y. (2016). Determination of heavy metals and other toxic ingredients in henna (Lawsonia inermis). Journal of Environmental & Analytical Toxicology, 6(3), 9.

Cebolla, S. G., [et al.]. (2018). Fully automated forensic routine dried blood spot screening for workplace testing. Journal of Analytical Toxicology, 43(2), 1–11.

Issa, S. Y., Hafez, E. M., El-Banna, A. S., Abdel Rahman, S. M., AlMazroua, M. K., … [et al.]. (2018). Baclofen systemic toxicity: Experimental histopathological and biochemical study. Human & Experimental Toxicology, 37(4), 431–441.

Zagloul, N. M., Farghaly, R. M., ELKhatib, H., Issa, S. Y., & El-Zoghby, S. M. (2022). Technology facilitated sexual violence: A comparative study between working and non-working females in Egypt before and during the COVID-19 pandemic. Egyptian Journal of Forensic Sciences, 12(1), 21.

Alalawi, S., Issa, S. T., Takshe, A. A., & ElBarazi, I. (2022). A review of the environmental implications of the COVID-19 pandemic in the United Arab Emirates. Environmental Challenges, 8, 100561.

Eddine, N. N., Noisel, N., Dieme, D., Asmar, M. K., Issa, S. T., & Bouchard, M. (2022). Multi-matrix biomonitoring approach to assess exposure to metals and trace elements in the Lebanese population and associations with drinking water consumption. Environmental Research, 214, 113982.